FORBES-TATE

Lobbying for ULTRAGENYX PHARMACEUTICAL · Clinical-state biopharmaceutical company

Filing Registration - Amendment

1st Quarter (Jan 1 - Mar 31) 2026 · California · posted Apr 17, 2026

Lobbying activity 1

Health Issues

Issues related to drug development and market access.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem